Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Clinical trial NCT02285062 · COMPLETED

Trial details

NCT number: NCT02285062
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2015-02-17
Primary completion: 2019-03-15
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.